RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Quality & Compliance: Structuring Combination Product Marketing Applications

Quality & Compliance: Structuring Combination Product Marketing Applications

Posted 01 September 2009

This article, the third in a series on FDA regulation of combination products, considers the structuring of combination product applications and its effect on downstream regulatory issues. It, along with two previous articles that discuss the problems in regulating combination products1 and combination product terminology,2 serves as a foundation for the remainder of the articles in this series.

 

© 2022 Regulatory Affairs Professionals Society.